Does the method of detection of breast cancer affect subsequent psychiatric morbidity?
The aim of this prospective study was to compare the prevalence of psychiatric morbidity following diagnosis of breast cancer between a group of women presenting with screen-detected cancer and a group presenting with symptomatic disease. Psychiatric symptoms were elicited using the Structured Clinical Interview (SCID) and classified according to DSM-III criteria. 61 (46%) of 132 women interviewed experienced an episode of psychiatric disorder between 1 month before diagnosis and 12 months post-diagnosis. There was no association between detection by screening of breast cancer and psychiatric disorder (Odds Ratio (OR) 0.8, 95% Confidence Interval (CI) 0.4-1.8 P=0.7). The occurrence of an episode of psychiatric disorder was associated with a previous history of treatment for psychological problems (OR 2.4, 95% CI 1.1-5.5, P=0.02). The results suggest there is no increased risk of developing psychiatric morbidity associated with the detection of cancer through the National Breast Screening Programme.
Cancer Research UK London Psychosocial Oncology Group, Guy's King's & St Thomas' School of Medicine, 3rd Floor, South Wing, Adamson Centre for Mental Health, St Thomas' Hospital, SE1 7EH, London, UK. caroline.burgess@kcl.ac.uk
C C
CC
Burgess
A J
AJ
Ramirez
M A
MA
Richards
H W W
HW
Potts
D000368:Aged; D001008:Anxiety Disorders / Q000209:etiology*; D001943:Breast Neoplasms / Q000175:diagnosis / Q000523:psychology*; D015331:Cohort Studies; D003866:Depressive Disorder / Q000209:etiology*; D005260:Female; D006801:Humans; D016015:Logistic Models; D008403:Mass Screening / Q000379:methods / Q000523:psychology; D008875:Middle Aged; D011446:Prospective Studies; D012044:Regression Analysis; D012307:Risk Factors